2,4-pyrimidinediamine compounds and their uses
Details for Australian Patent Application No. 2003208931 (hide)
International Classifications
Event Publications
17 July 2003 Complete Application Filed
Priority application(s): 60/353,267 01.02.02 US; 60/434,277 17.12.02 US; 60/399,673 29.07.02 US; 60/353,333 01.02.02 US
18 September 2003 Application Open to Public Inspection
Published as AU-B-2003208931
4 September 2008 Application Accepted
Published as AU-B-2003208931
2 April 2009 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 03 Nov 2008
9 April 2009 Standard Patent Sealed
17 May 2012 Licence Registered
Rigel Pharmaceuticals, Inc. ( AstraZeneca AB )
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser